Stem Cell Therapies in CVMD
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Regenerative medicine could potentially cure diseases and may replace palliative treatments for chronic diseases. Stem cells in particular have been studied for their regenerative properties: their potential to repair or replace damaged or diseased human cells or tissues to restore normal function. Studies of stem cell therapies targeting cardiovascular indications such as heart failure (HF), myocardial infarction (MI), cardiomyopathy (CM), and left ventricular dysfunction (LVD) aim to demonstrate that stem cells injected into the circulation or directly into the injured heart tissue improve cardiac function and/or induce the formation of new capillaries.
This report provides an assessment of the pipeline, clinical, and commercial landscape of stem cell therapies in CVMD. Overall, GlobalData expects new stem cell therapy approvals to drive CVMD market growth from 2018–2025.
Scope
GlobalData’s Hot Topic: Stem Cell Therapies in CVMD combines KOL and Payer insights along with data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the slide deck include:
• Overview of CVMD and Stem Cells—epidemiology and regulatory oversight
• Pipeline Assessment—regional breakdown, promising late-stage products, early-stage pipeline by molecule type
• Clinical Trials Assessment—trial breakdown by phase, leading industry and non-industry sponsors
• Market Access—considerations for reimbursement, pricing, and unmet needs
• Market Outlook—competitive assessment and key market events (2018–2025)
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global CVMD stem cell therapy market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CVMD stem cell therapy market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
U.S. Stemcell
Celixir
Capricor
Stemedica
Healios
Athersys
SanBio
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.